A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis B.
about
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelinesNew virologic tools for management of chronic hepatitis B and CComparison of three luminescent immunoassays for hepatitis B virus surface antigen quantification during the natural history of chronic hepatitis B virus infection.Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.Elecsys hepatitis B surface antigen quantitative assay: performance evaluation and correlation with hepatitis B virus DNA during 96 weeks of follow-up in chronic hepatitis B patients.Analysis of mutations in the S gene of hepatitis B virus strains in patients with chronic infection by online bioinformatics tools.Efficacy and safety of a chinese herbal formula (invigorating kidney and strengthening spleen) in chronic hepatitis B virus carrier: results from a multicenter, randomized, double-blind, and placebo-controlled trialThe role of HBsAg quantification for monitoring natural history and treatment outcome.HBsAg quantification: useful for monitoring natural history and treatment outcome.HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?Hepatitis B surface antigen quantification in chronic hepatitis B and its clinical utility.Multicenter evaluation of the Elecsys hepatitis B surface antigen quantitative assay.Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study.Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centres.HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy.Comparison of two immunoassays for quantification of hepatitis B surface antigen in Chinese patients with concomitant hepatitis B surface antigen and hepatitis B surface antibodies.Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.Loss of HBsAg and antiviral treatment: from basics to clinical significance.The role of HBsAg levels in the current management of chronic HBV infection.Quantification of hepatitis B surface antigen and E antigen: correlation between Elecsys and architect assays.Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels.Performance evaluation of new automated hepatitis B viral markers in the clinical laboratory: two quantitative hepatitis B surface antigen assays and an HBV core-related antigen assay.
P2860
Q27000080-82A200CC-9113-49D9-A9B0-8F2AD6DF0D9FQ27026914-0F431AD5-422D-45C2-B9A2-80C7942DDCB7Q34592952-DCC4BD92-DF44-4E11-A899-8C0AAB3DD379Q35739079-C4FF9CE1-3DBD-4898-A253-59D332D55294Q36365030-D39B8F39-232B-4330-8F11-38A70FE39F47Q36506360-B7544446-4808-44B4-B52C-57BFC55215E8Q37043981-7A80D2A6-AFEA-4469-A979-2110AFA08DABQ38071397-041CC437-2C96-4964-8C22-A147E4F9AFF4Q38174257-1F6BB9EB-4CC2-482F-9CD0-3C55B2C401FEQ38174261-6C637888-BC7C-466D-9B8C-287B07998392Q38177851-2D178514-712F-4790-BB54-F51C2144C81EQ38955049-90C31CD3-0E7F-42BC-BB0E-E78711AC59EEQ39903061-27D19E8D-3C11-41E8-A040-974E40955464Q40117484-60C59568-70EC-4079-81E4-9993AF957D2DQ41718138-B1EA4215-6A11-4493-86C5-7BDAD48971D2Q42183410-F3AF8C6F-D01E-4D8E-BCD3-EE1CB048F51BQ42203091-8D17D664-9BB4-403F-9FE7-156F4A0A30CAQ42235230-A77D917A-CB29-4D95-AF4C-B7737C79183CQ42360905-BB172087-812A-4BF3-BA3B-E98A2C72F218Q43521365-B642B6C9-7ADE-4FC9-81C0-78836706E0CEQ44408807-8085EA5E-7B66-4F1C-ADA0-9141F90881EDQ53379528-21CCFB0B-465F-47A1-A054-C18A8CDE319F
P2860
A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis B.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
A comparison of two assays for ...... ents with chronic hepatitis B.
@en
A comparison of two assays for ...... ents with chronic hepatitis B.
@nl
type
label
A comparison of two assays for ...... ents with chronic hepatitis B.
@en
A comparison of two assays for ...... ents with chronic hepatitis B.
@nl
prefLabel
A comparison of two assays for ...... ents with chronic hepatitis B.
@en
A comparison of two assays for ...... ents with chronic hepatitis B.
@nl
P2093
P1476
A comparison of two assays for ...... ents with chronic hepatitis B.
@en
P2093
Charles A B Boucher
Harry L A Janssen
Louwerens Zwang
Matthias F C Beersma
Milan J Sonneveld
Vincent Rijckborst
P304
P356
10.1016/J.JCV.2011.04.005
P577
2011-05-17T00:00:00Z